|
Volumn 11, Issue 4, 2015, Pages 725-726
|
SAR405, a PIK3C3/VPS34 inhibitor that prevents autophagy and synergizes with MTOR inhibition in tumor cells
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MAMMALIAN TARGET OF RAPAMYCIN;
PROTEIN KINASE INHIBITOR;
SAR 405;
UNCLASSIFIED DRUG;
MTOR PROTEIN, HUMAN;
PHOSPHATIDYLINOSITOL 3 KINASE;
PYRIDINE DERIVATIVE;
PYRIMIDINONE DERIVATIVE;
SAR405;
TARGET OF RAPAMYCIN KINASE;
AUTOPHAGY;
CELL PROLIFERATION;
ENDOSOME;
ENZYME INHIBITION;
FEMALE;
HUMAN;
HUMAN CELL;
LYSOSOME;
NOTE;
TUMOR CELL;
ANTAGONISTS AND INHIBITORS;
DRUG EFFECTS;
METABOLISM;
PHAGOSOME;
PHYSIOLOGY;
TUMOR CELL LINE;
AUTOPHAGY;
CELL LINE, TUMOR;
CELL PROLIFERATION;
CLASS III PHOSPHATIDYLINOSITOL 3-KINASES;
ENDOSOMES;
HUMANS;
LYSOSOMES;
PHAGOSOMES;
PROTEIN KINASE INHIBITORS;
PYRIDINES;
PYRIMIDINONES;
TOR SERINE-THREONINE KINASES;
|
EID: 84952671082
PISSN: 15548627
EISSN: 15548635
Source Type: Journal
DOI: 10.1080/15548627.2015.1033601 Document Type: Note |
Times cited : (128)
|
References (0)
|